Showing results (11-20 of 137) with videos related to
Sort By:
Pageof 14
Translational Lung Cancer Research|July 23, 2021
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populationsRoberto Ferrara, Diego Signorelli, Claudia Proto, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Is hyperprogressive disease a specific phenomenom of immunotherapy?Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, et al.Journal of Experimental & Clinical Cancer Research : CR|August 2, 2013
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachFederica Tomao, Anselmo Papa, Luigi Rossi, et al.Current Oncology Reports|August 4, 2016
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung CancerRaffaele Califano, Keith Kerr, Robert David Morgan, et al.Frontiers in Oncology|January 10, 2019
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature ReviewGiuseppe Lo Russo, Anna Tessari, Marina Capece, et al.Tumori|July 15, 2017
Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanismsClaudia Proto, Giuseppe Lo Russo, Giulia Corrao, et al.Recent Patents on Anti-Cancer Drug Discovery|January 24, 2012
Emerging role of cetuximab in the treatment of colorectal cancerAnselmo Papa, Luigi Rossi, Giuseppe Lo Russo, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2013
Circulating tumor cells in high-risk nonmetastatic colorectal cancerPaola Gazzaniga, Walter Gianni, Cristina Raimondi, et al.Journal of Medical Case Reports|March 7, 2019
Combined surgery and radiotherapy as curative treatment for tracheal adenoid cystic carcinoma: a case reportGian Paolo Spinelli, Evelina Miele, Alessandra Anna Prete, et al.Critical Reviews in Oncology/Hematology|December 22, 2023
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinibGiuseppe Lo Russo, Paolo Bironzo, Chiara Bennati, et al.Pageof 14